Fig. 6From: Patient-derived scaffolds influence secretion profiles in cancer cells mirroring clinical features and breast cancer subtypesSubgroups of PDSs correlated to gene expression and relapse-free survival. a, b Upregulation of the EMT markers SNAI2 (pSOM1-SOM2 = 0.020 and pSOM1-SOM3 = 0.037) and VIM (pSOM1-SOM2 = 0.027) in MCF7 cells grown in PDSs. Calculated by one-way ANOVA and Tukey’s multiple comparisons test (n = 42). c Kaplan Meier- plot showing the differences in relapse-free survival of patients in the three SOM-groups. pSOM1 = 0.013 (n = 50)Back to article page